vs
Side-by-side financial comparison of CBL International Ltd (BANL) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $277.2M, roughly 1.4× CBL International Ltd). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -0.6%, a 3.6% gap on every dollar of revenue.
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
BANL vs LFST — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $277.2M | $382.2M |
| Net Profit | $-1.6M | $11.7M |
| Gross Margin | 1.0% | — |
| Operating Margin | -0.5% | 4.7% |
| Net Margin | -0.6% | 3.1% |
| Revenue YoY | — | 17.4% |
| Net Profit YoY | — | 264.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $382.2M | ||
| Q3 25 | — | $363.8M | ||
| Q2 25 | $277.2M | $345.3M | ||
| Q1 25 | — | $333.0M | ||
| Q4 24 | $592.5M | $325.5M | ||
| Q3 24 | — | $312.7M | ||
| Q2 24 | $192.0M | $312.3M | ||
| Q1 24 | — | $300.4M |
| Q4 25 | — | $11.7M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | $-1.6M | $-3.8M | ||
| Q1 25 | — | $709.0K | ||
| Q4 24 | $-3.9M | $-7.1M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-23.3M | ||
| Q1 24 | — | $-21.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | -0.5% | -0.9% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | -0.6% | 0.3% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | -0.6% | -1.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | -0.7% | -2.2% | ||
| Q3 24 | — | -1.9% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | — | -7.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $248.6M |
| Total DebtLower is stronger | — | $282.8M |
| Stockholders' EquityBook value | $22.9M | $1.5B |
| Total Assets | $69.3M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | $8.0M | $154.6M | ||
| Q3 24 | — | $102.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $22.9M | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $22.9M | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $25.3M | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $69.3M | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $69.3M | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $53.5M | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $57.6M |
| Free Cash FlowOCF − Capex | — | $46.6M |
| FCF MarginFCF / Revenue | — | 12.2% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | — | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $57.6M | ||
| Q3 25 | — | $27.3M | ||
| Q2 25 | — | $64.4M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | $-1.9M | $62.3M | ||
| Q3 24 | — | $22.7M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | — | $-21.8M |
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | $-2.1M | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $-26.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | -0.4% | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | -9.0% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 0.0% | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
